SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellular Biomedicine Group Inc. – CBMG

April 9, 2015

 

NEW YORK, April 7, 2015 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Cellular Biomedicine Group Inc. (“CBMG” or the “Company”) (NASDAQ: CBMG). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The investigation concerns whether CBMG and certain of its officers and/or directors have violated…

Search

RECENT PRESS RELEASES

Related Post

Is Meta Stock A Buy? Facebook Parent Shares Rebound After Tariff Deal, Q1 Earnings
Is Meta Stock A Buy? Facebook Parent Shares Rebound After Tariff Deal, Q1 Earnings
Gallery

Is Meta Stock A Buy? Facebook Parent Shares Rebound After Tariff Deal, Q1 Earnings

May 28, 2025
The market just gave investors a gift. Here’s how not to blow it, according to investing e
The market just gave investors a gift. Here’s how not to blow it, according to investing e
Gallery

The market just gave investors a gift. Here’s how not to blow it, according to investing e

May 18, 2025
The Clean Energy Tax Debate Will Shape America’s Economic Future
The Clean Energy Tax Debate Will Shape America’s Economic Future
Gallery

The Clean Energy Tax Debate Will Shape America’s Economic Future

May 16, 2025
Ethereum Network Activity Spikes As Price Rallies – Bullish Reversal Coming?
Ethereum Network Activity Spikes As Price Rallies – Bullish Reversal Coming?
Gallery

Ethereum Network Activity Spikes As Price Rallies – Bullish Reversal Coming?

April 23, 2025